Ondexxya 200 mg, Pulver zur Herstellung einer Infusionslösung

7680677590023 CH-67759 Pulver
Ondexxya 200 mg, Pulver zur Herstellung einer Infusionslösung
Ondexxya 200 mg, Pulver zur Herstellung einer Infusionslösung
Ondexxya 200 mg, Pulver zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
5
Selling units
5
Measure
Durchstechflasche(n)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
30/04/2025
Summary of Product Characteristics
Français
30/04/2025
Summary of Product Characteristics
Italien
30/04/2025

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

AstraZeneca AG

6340 Baar

Authorization information

Swissmedic authorization number
67759
Drug name
Ondexxya, Pulver zur Herstellung einer Infusionslösung
Galenic form
PULVI
ATC Code
V03AB38
Authorization status
Z
Dispensing category
A
First authorization
02/12/2020
Authorization expiration date
29/07/2029
IT Number
15.01.0.
Domain
Human medicine
Field of application
Antidot gegen Faktor Xa-Inhibitoren

Package details

Description (FR)
ONDEXXYA subst sèche 200 mg flac 5 pce
Description (DE)
ONDEXXYA Trockensub 200 mg Durchstf 5 Stk
Market launch
02/12/2020
Narcotic (BTM)
No

Other package sizes (1)

ONDEXXYA subst sèche 200 mg flac 4 pce
4 DUR
GTIN: 7680677590016
View